Closing in on the killers:
Advances in cancer research

• While inroads have been made in developing cancer treatments, many therapies harm the cancer cells and the patient. Researchers need a way to study cancer cells more holistically, looking at both dead and living cells, so they can develop targeted treatments that stop cancer growth without harming the patient.
• Agilent scientists integrated industry leading platforms - BioTek, Acea, Seahorse and Luxcel - with Agilent's mass spectrometry. This unique combination allows scientists to measure cancer morphologically, sub- cellularly and non-invasively.
• Researchers can develop targeted therapies that treat the cancer without harming the patient.

Explore more great science